E156 Micro-Paper · Africa Clinical Trials

Sahel Belt Void

The Sahel belt — stretching from Mauritania to Chad — combines extreme poverty, ...

Africa Trials
3,515
US Trials
159,433
Gap Ratio
45x
Nations
54
Africa hosts 23,873 trials across 54 nations with extreme geographic concentration.
Sahel Belt Void by Country Egypt: N/A Algeria: N/A Morocco: N/A Tunisia: N/A Senegal: 113 Ghana: N/A Nigeria: N/A Cameroon: N/A DRC: N/A Ethiopia: N/A Kenya: N/A Uganda: N/A Tanzania: N/A Rwanda: N/A South Africa: N/A Sen 113 2 215
Regional Comparison Africa US Europe 0 50000 100000 150000 200000
Enrollment Distribution Africa Reference 10000 20000 30000
No data
Contribution Breakdown 215 Burkina Fa 183 Mali 113 Senegal 44 Niger 9 Chad 2 Others
Research Profile Volume Growth Phase3 Complete Diversity
Burden vs Investment 50000 100000 150000 50000 100000 150000 Africa US Europe
No data
Why It Matters

The Sahel belt — stretching from Mauritania to Chad — combines extreme poverty, climate vulnerability, and active conflict, creating a vast research void across six nations with a combined population exceeding 100 million.

In the spatial mapping of African clinical research, does the pattern of sahel belt void reveal structural inequity in African research investment? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the Bayesian posterior trial rate as the primary estimand using registry metadata for each nation. Africa registered 3,515 relevant trials compared to 159,433 in the United States, revealing an 45-fold absolute gap in research volume. Shannon entropy of the trial distribution was 1.93 bits, confirming substantial concentration beyond random variation. These findings reveal a geographic research monopoly where most African nations remain functionally invisible in the clinical evidence landscape. Interpretation is limited by reliance on ClinicalTrials.gov alone, which may undercount locally registered African studies.
Question

In the spatial mapping of African clinical research, does the pattern of sahel belt void reveal structural inequity in African research investment?

Dataset

This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.

Method

gov through April 2026.

Primary Result

Investigators computed the Bayesian posterior trial rate as the primary estimand using registry metadata for each nation.

Robustness

Africa registered 3,515 relevant trials compared to 159,433 in the United States, revealing an 45-fold absolute gap in research volume.

Interpretation

Shannon entropy of the trial distribution was 1.

Boundary

93 bits, confirming substantial concentration beyond random variation.

Extra

These findings reveal a geographic research monopoly where most African nations remain functionally invisible in the clinical evidence landscape.

Extra

Interpretation is limited by reliance on ClinicalTrials.

Extra

gov alone, which may undercount locally registered African studies.